319 results on '"Galajda, Peter"'
Search Results
52. Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?
53. A wall of funnels concentrates swimming bacteria
54. Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases
55. Heparin induced thrombocytopenia and up to date options of treatment - review of literature
56. Type 2 Diabetes and Fibrinolysis
57. Recidivujúce uroinfekcie u pacientov po transplantácii obličky s polycystickou chorobou obličiek.
58. Apixaban: An Optimal Agent for the Treatment of Cancer-Associated Venous Thromboembolism?
59. Glycated haemoglobin as a marker of elevated LDL and TAG: a cohort study
60. Assessing the hemostasis with thromboelastometry in direct oral anticoagulants-treated patients with atrial fibrillation
61. Anti-Xa Activity-Guided Edoxaban Therapy for Cancer-Associated Venous Thromboembolism?
62. The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation
63. Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low–Immunologic Risk Kidney Transplant Recipients
64. Soluble P-Selectin During a Single Hemodialysis Session in Patients With Chronic Renal Failure and Erythropoietin Treatment
65. Brugada syndrome diagnosed after ventricular fibrillation with anamnesis of fever
66. Proton Pump Inhibitors and Dabigatran Therapy: Impact on Gastric Bleeding and Dabigatran Plasma Levels
67. Scoring systems stratifying the risk of bleeding, thromboembolism in patients with atrial fibrillation and haemorhagic shock of the patient with triple therapy
68. Primary and secondary insulin resistance
69. Role of sex in post-transplant diabetes mellitus development: Are men and women equal?
70. Therapeutic plasma exchange in secondary prevention of acute pancreatitis in pregnant patient with familial hyperchylomicronemia
71. Labeling phosphorylated LHCII with microspheres for tracking studies and force measurements
72. Heparínom indukovaná trombocytopénia a aktuálne možnosti liečby - prehľad literatúry.
73. Glykovaný hemoglobín ako marker zvýšenia LDL a TAG - kohortná štúdia.
74. How to proceed with long-term anticoagulation in patient after total gastrectomy and atrial fibrillation?
75. Does proton pump inhibition change the on-treatment anti-Xa activity in xabans-treated patients with atrial fibrillation? A pilot study
76. Leptin – A new marker for development of post-transplant diabetes mellitus?
77. Is Amanita phalloides poisoning still a problem?
78. Anti-Xa activity in oral factor Xa inhibitor-treated patients with atrial fibrillation and a higher risk of bleeding
79. Dabigatran Levels in Elderly Patients with Atrial Fibrillation: First Post-Marketing Experiences
80. SP704LEPTIN - A NEW MARKER OF ACUTE REJECTION?
81. A consensual therapeutic recommendation for type 2 diabetes mellitus by the Slovak Diabetes Society (2018)
82. Insulin Pump Therapy – Influence on Body Fat Redistribution, Skeletal Muscle Mass and Ghrelin, Leptin Changes in T1D Patients
83. A rare cause of acute myocardial infarction in a 20-year-old patient diagnosed with severe ketoacidosis
84. Type 2 Diabetes and ADP Receptor Blocker Therapy
85. Selfish and Altruistic Bacterial Populations Maximize Fitness Under Stress by Local Segregation
86. Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal
87. Porovnanie skorovacich systemov na stanovenie rizika krvacania a tromboembolizmu u pacientov s fibrilaciou predsieni a hemoragicky šok u pacienta na triple terapii.
88. Porovnanie skórovacích systémov na stanovenie rizika krvácania a tromboembolizmu u pacientov s fibriláciou predsiení a hemoragický šok u pacienta na triple terapii.
89. Body mass index before kidney transplantation — principal risk factor for NODAT
90. Ticagrelor
91. The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study
92. Konsenzuálne terapeutické odporúčanie Slovenskej diabetologickej spoločnosti pre diabetes mellitus 2. typu (2018).
93. Nezvyčajná príčina akútneho infarktu myokardu u 20-ročnej pacientky s ťažkou ketoacidózou.
94. The idiosyncrasy of spatial structure in bacterial competition
95. The Intricate Network of Adipokines and Stroke
96. Prasugrel loading dose in diabetic patients with acute STEMI - Always sufficiently effective? Observation in two cases and review of current knowledge
97. Monitoring of dabigatran therapy using Hemoclot® Thrombin Inhibitor assay in patients with atrial fibrillation
98. The effects of chemical interactions and culture history on the colonization of structured habitats by competing bacterial populations
99. Thromboembolic disease and present oral contraception
100. Type 2 Diabetes and Fibrinolysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.